Fig. 4 .

Impact of TERT promoter mutation on patient prognosis. (A, B) TERT promoter mutation status was compared with OS and (C) time to recurrence. (A) Kaplan–Meier plots for patient subgroups according to TERTp-wt and TERTp-mut variants are shown for the entire meningioma cohort and (B) for the anaplastic meningioma WHO grade III collective. (C) Comparison of meningioma patient subgroups with different TERT promoter status regarding “probability of no recurrence with time” (C). Numbers below the Kaplan–Meier survival plots (A, B, C) indicate patients at risk at timepoints 0, 100, and 200 months.